Skip to main content
TipRanks
Go Ultimate75% OFF

Relay Therapeutics (RLAY) Revenue

636 Followers

Relay Therapeutics Revenue

Relay Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 10.35M, Increased 0.00%. In the fiscal year ending Dec 31, 2025, Relay Therapeutics had annual revenue of 15.36M with 53.44% growth.

Revenue (ttm)
10.35M
Revenue Growth
23.86%
P/S Ratio
286.94
Revenue/Employee
$76,015
Employees
202
Market Cap
$4.41B

Revenue Chart

Relay Therapeutics Revenue - Annual

020M40M60M80M100M82.65M3.03M1.38M25.55M10.01M15.36M20182019202020212022202320242025
Revenue History
Download to Excel
RLAY revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202515.36M5.35M53.44%
Dec 31, 202410.01M-15.54M-60.83%
Dec 31, 202325.55M24.16M1749.82%
Dec 31, 20221.38M-1.65M-54.41%
Dec 31, 20213.03M-79.63M-96.34%
Dec 31, 202082.65M82.65M―
Dec 31, 20190.000.00―
Dec 31, 20180.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
RLAY10.35M
IDYA36.53M
TNGX0.00
EWTX0.00
GLUE70.33M
ERAS0.00